The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Applications of iPSC-derived beta cells from patients with diabetes
Abstract
Improved stem cell-derived pancreatic islet (SC-islet) differentiation protocols robustly generate insulin-secreting β cells from patient induced pluripotent stem cells (iPSCs). These advances are enabling in vitro disease modeling studies and the development of an autologous diabetes cell replacement therapy. SC-islet technology elucidates key features of human pancreas development and diabetes disease progression through the generation of pancreatic progenitors, endocrine progenitors, and β cells derived from diabetic and nondiabetic iPSCs. Combining disease modeling with gene editing and next-generation sequencing reveals the impact of diabetes-causing mutations and diabetic phenotypes on multiple islet cell types. In addition, the supply of SC-islets, containing β and other islet cell types, is unlimited, presenting an opportunity for personalized medicine and overcoming several disadvantages posed by donor islets. This review highlights relevant studies involving iPSC-β cells and progenitors, encompassing new conclusions involving cells from patients with diabetes and the therapeutic potential of iPSC-β cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ability to generate large numbers of insulin-producing cells from human pluripotent SC can restore normal endogenous insulin production and effectively manage diabetes in both animal models4,5 and human patients6–10.”
From Scale up manufacturing approach for production of human induced pluripotent stem cell-derived islets using Vertical Wheel® bioreactors (2025) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Generation of Functional Human Pancreatic β Cells In Vitro
Pagliuca, F. W., Millman, J. R., Gürtler, M., Segel, M., Van Dervort, A., Ryu, J. H., Peterson, Q. P., Greiner, D., & Melton, D. A. (2014) · Cell · doi:10.1016/j.cell.2014.09.040 · Cited by 2,025 · cited 2×
“Protocols were typically optimized for a single ESC line, producing iPSC-b cells at lower efficiencies.(10,11,14) SC-b or SC-b-like cells ranged from 17%(27) to 73%(14) C-Peptide, a proxy marker for insulin, at the final stage of differentiation.”
BackgroundMethodSelf-citationInternational trial of the Edmonton protocol for islet transplantation
Shapiro, A. M. J., Ricordi, C., Hering, B. J., Auchincloss, H., Lindblad, R., Robertson, R. P., Secchi, A., Brendel, M. D., Berney, T., Brennan, D. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061267 · Cited by 1,942
Kroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., Young, H., Richardson, M., Smart, N. G., Cunningham, J., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1393 · Cited by 1,843 · cited 1×
“Nephrectomies were also commonly performed to confirm that the transplanted cells were the source of euglycemia in kidney capsule transplants.(9,12,17,24,75,76) Several groups confirmed the maturation of SC-islets, SC-b cells, and PPs post-transplantation with immunostaining.”
BackgroundFive-Year Follow-Up After Clinical Islet Transplantation
Ryan, E. A., Paty, B. W., Senior, P. A., Bigam, D., Alfadhli, E., Kneteman, N. M., Lakey, J. R. T., & Shapiro, A. M. J. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2060 · Cited by 1,641
Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells
Rezania, A., Bruin, J. E., Arora, P., Rubin, A., Batushansky, I., Asadi, A., O'Dwyer, S., Quiskamp, N., Mojibian, M., Albrecht, T., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.3033 · Cited by 1,575
Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes
Segerstolpe, Å., Palasantza, A., Eliasson, P., Andersson, E.-M., Andréasson, A.-C., Sun, X., Picelli, S., Sabirsh, A., Clausen, M., Bjursell, M. K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.020 · Cited by 1,550
Deuse, T., Hu, X., Gravina, A., Wang, D., Tediashvili, G., De, C., Thayer, W. O., Wahl, A., Garcia, J. V., Reichenspurner, H., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0016-3 · Cited by 758
Hering, B. J., Clarke, W. R., Bridges, N. D., Eggerman, T. L., Alejandro, R., Bellin, M. D., Chaloner, K., Czarniecki, C. W., Goldstein, J. S., Hunsicker, L. G., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1988 · Cited by 645
Research works printed but not linked: 70
- Meloche, 2007, Transplantation for the treatment of type 1 diabetes, World J. Gastroenterol., 13, 6347, 10.3748/wjg.v13.i47.6347 · doi:10.3748/wjg.v13.i47.6347
- Kharroubi, 2015, Diabetes mellitus: the epidemic of the century, World J. Diabetes, 6, 850, 10.4239/wjd.v6.i6.850 · DOI · Paper page
- Schwartz, 2017, A unified pathophysiological construct of diabetes and its complications, Trends Endocrinol. Metab., 28, 645, 10.1016/j.tem.2017.05.005 · DOI
- D’Amour, 2006, Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells, Nat. Biotechnol., 24, 1392, 10.1038/nbt1259 · DOI · Paper page
- D’Amour, 2005, Efficient differentiation of human embryonic stem cells to definitive endoderm, Nat. Biotechnol., 23, 1534, 10.1038/nbt1163 · DOI · Paper page
- Balboa, 2018, Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes, eLife, 7, e38519, 10.7554/eLife.38519 · DOI
- Ma, 2018, β cell replacement after gene editing of a neonatal diabetes-causing mutation at the insulin locus, Stem Cell Reports, 11, 1407, 10.1016/j.stemcr.2018.11.006 · DOI
- Tran, 2020, Developmentally-Inspired Biomimetic Culture Models to Produce Functional Islet-Like Cells From Pluripotent Precursors, Front. Bioeng. Biotechnol., 8, 583970, 10.3389/fbioe.2020.583970 · DOI
- Nostro, 2012, Generation of beta cells from human pluripotent stem cells: potential for regenerative medicine, Semin. Cell Dev. Biol., 23, 701, 10.1016/j.semcdb.2012.06.010 · DOI
- Velazco-Cruz, 2020, Advances Toward Engineering Functionally Mature Human Pluripotent Stem Cell-Derived β Cells, Front. Bioeng. Biotechnol., 8, 786, 10.3389/fbioe.2020.00786 · DOI
- Theis, 2019, A map of β-cell differentiation pathways supports cell therapies for diabetes, Nature, 569, 342, 10.1038/d41586-019-01211-9 · DOI
- Aguayo-Mazzucato, 2010, Stem cell therapy for type 1 diabetes mellitus, Nat. Rev. Endocrinol., 6, 139, 10.1038/nrendo.2009.274 · DOI · Paper page
- Tremmel, 2019, Mimicking nature-made beta cells: recent advances towards stem cell-derived islets, Curr. Opin. Organ Transplant., 24, 574, 10.1097/MOT.0000000000000687 · DOI
- Sui, 2018, β-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells, Diabetes, 67, 26, 10.2337/db17-0120 · DOI
- Veres, 2019, Charting cellular identity during human in vitro β-cell differentiation, Nature, 569, 368, 10.1038/s41586-019-1168-5 · DOI · Paper page
- Cosentino, 2018, Pancreatic β-cell tRNA hypomethylation and fragmentation link TRMT10A deficiency with diabetes, Nucleic Acids Res., 46, 10302, 10.1093/nar/gky839 · DOI
- Nostro, 2015, Efficient generation of NKX6-1+ pancreatic progenitors from multiple human pluripotent stem cell lines, Stem Cell Reports, 4, 591, 10.1016/j.stemcr.2015.02.017 · DOI · Paper page
- Russ, 2015, Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro, EMBO J., 34, 1759, 10.15252/embj.201591058 · DOI · Paper page
- Kudva, 2012, Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes, Stem Cells Transl. Med., 1, 451, 10.5966/sctm.2011-0044 · DOI
- Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
- Leite, 2020, Modeling Type 1 Diabetes In Vitro Using Human Pluripotent Stem Cells, Cell Rep., 32, 107894, 10.1016/j.celrep.2020.107894 · DOI
- Wang, 2019, Point mutations in the PDX1 transactivation domain impair human β-cell development and function, Mol. Metab., 24, 80, 10.1016/j.molmet.2019.03.006 · DOI
- Dwivedi, 2019, Loss of ZnT8 function protects against diabetes by enhanced insulin secretion, Nat. Genet., 51, 1596, 10.1038/s41588-019-0513-9 · DOI
- Amin, 2018, Discovery of a drug candidate for GLIS3-associated diabetes, Nat. Commun., 9, 2681, 10.1038/s41467-018-04918-x · DOI
- Millman, 2016, Generation of stem cell-derived β-cells from patients with type 1 diabetes, Nat. Commun., 7, 11463, 10.1038/ncomms11463 · DOI · Paper page
- Thatava, 2013, Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells, Mol. Ther., 21, 228, 10.1038/mt.2012.245 · DOI
- Lithovius, 2021, SUR1-mutant iPS cell-derived islets recapitulate the pathophysiology of congenital hyperinsulinism, Diabetologia, 64, 630, 10.1007/s00125-020-05346-7 · DOI
- Cardenas-Diaz, 2019, Modeling Monogenic Diabetes using Human ESCs Reveals Developmental and Metabolic Deficiencies Caused by Mutations in HNF1A, Cell Stem Cell, 25, 273, 10.1016/j.stem.2019.07.007 · DOI
- Kishore, 2020, A Non-Coding Disease Modifier of Pancreatic Agenesis Identified by Genetic Correction in a Patient-Derived iPSC Line, Cell Stem Cell, 27, 137, 10.1016/j.stem.2020.05.001 · DOI
- Stepniewski, 2015, Induced pluripotent stem cells as a model for diabetes investigation, Sci Rep, 5, 8597, 10.1038/srep08597 · DOI
- Shang, 2014, β-cell dysfunction due to increased ER stress in a stem cell model of Wolfram syndrome, Diabetes, 63, 923, 10.2337/db13-0717 · DOI · Paper page
- Teo, 2013, Derivation of Human Induced Pluripotent Stem Cells from Patients with Maturity Onset Diabetes of the Young, J Biol Chem, 288, 5353, 10.1074/jbc.C112.428979 · DOI
- Steiner, 2010, Pancreatic islet plasticity: interspecies comparison of islet architecture and composition, Islets, 2, 135, 10.4161/isl.2.3.11815 · DOI · Paper page
- Eizirik, 1994, Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury, Proc. Natl. Acad. Sci. USA, 91, 9253, 10.1073/pnas.91.20.9253 · DOI · Paper page
- Simsek, 2016, Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells, Stem Cells Transl. Med., 5, 572, 10.5966/sctm.2015-0276 · DOI
- Harris, 2018, Monogenic diabetes: the impact of making the right diagnosis, Curr. Opin. Pediatr., 30, 558, 10.1097/MOP.0000000000000643 · DOI
- Augsornworawat, 2020, Single-cell RNA sequencing for engineering and studying human islets, Curr. Opin. Biomed. Eng., 16, 27, 10.1016/j.cobme.2020.06.003 · DOI
- Muraro, 2016, A single-cell transcriptome atlas of the human pancreas, Cell Syst., 3, 385, 10.1016/j.cels.2016.09.002 · DOI · Paper page
- Krentz, 2018, Single-Cell Transcriptome Profiling of Mouse and hESC-Derived Pancreatic Progenitors, Stem Cell Reports, 11, 1551, 10.1016/j.stemcr.2018.11.008 · DOI
- Hakonen, 2018, MANF protects human pancreatic beta cells against stress-induced cell death, Diabetologia, 61, 2202, 10.1007/s00125-018-4687-y · DOI
- Misun, 2020, In Vitro Platform for Studying Human Insulin Release Dynamics of Single Pancreatic Islet Microtissues at High Resolution, Adv. Biosyst., 4, e1900291, 10.1002/adbi.201900291 · DOI
- Lenguito, 2017, Resealable, optically accessible, PDMS-free fluidic platform for ex vivo interrogation of pancreatic islets, Lab Chip, 17, 772, 10.1039/C6LC01504B · DOI
- Jun, 2019, In vivo-mimicking microfluidic perfusion culture of pancreatic islet spheroids, Sci. Adv., 5, eaax4520, 10.1126/sciadv.aax4520 · DOI
- Sankar, 2011, Culturing pancreatic islets in microfluidic flow enhances morphology of the associated endothelial cells, PLoS ONE, 6, e24904, 10.1371/journal.pone.0024904 · DOI
- Glieberman, 2019, Synchronized stimulation and continuous insulin sensing in a microfluidic human islet on a chip designed for scalable manufacturing, Lab Chip, 19, 2993, 10.1039/C9LC00253G · DOI
- Ishahak, 2019, Integrated platform for operating and interrogating organs-on-chips, Anal. Methods, 11, 5645, 10.1039/C9AY01663E · DOI
- Wesolowska-Andersen, 2020, Analysis of Differentiation Protocols Defines a Common Pancreatic Progenitor Molecular Signature and Guides Refinement of Endocrine Differentiation, Stem Cell Reports, 14, 138, 10.1016/j.stemcr.2019.11.010 · DOI
- Li, 2020, Single-Cell RNA-Seq Reveals that CD9 Is a Negative Marker of Glucose-Responsive Pancreatic β-like Cells Derived from Human Pluripotent Stem Cells, Stem Cell Reports, 15, 1111, 10.1016/j.stemcr.2020.09.009 · DOI
- Zhu, 2017, PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration, Stem Cell Res. Ther., 8, 240, 10.1186/s13287-017-0694-z · DOI · Paper page
- Eichstadt, 2019, Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa, JCI Insight, 4, 130554, 10.1172/jci.insight.130554 · DOI
- Río, 2019, Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia, Nat. Med., 25, 1396, 10.1038/s41591-019-0550-z · DOI · Paper page
- Lee, 2020, Recent advances in genome editing of stem cells for drug discovery and therapeutic application, Pharmacol. Ther., 209, 107501, 10.1016/j.pharmthera.2020.107501 · DOI
- Sackett, 2017, The nexus of stem cell-derived beta-cells and genome engineering, Rev. Diabet. Stud., 14, 39, 10.1900/RDS.2017.14.39 · DOI
- Millman, 2017, Autologous Pluripotent Stem Cell-Derived β-Like Cells for Diabetes Cellular Therapy, Diabetes, 66, 1111, 10.2337/db16-1406 · DOI
- Stock, 2020, Conformal Coating of Stem Cell-Derived Islets for β Cell Replacement in Type 1 Diabetes, Stem Cell Reports, 14, 91, 10.1016/j.stemcr.2019.11.004 · DOI · Paper page
- Zhu, 2016, Human pancreatic beta-like cells converted from fibroblasts, Nat. Commun., 7, 10080, 10.1038/ncomms10080 · DOI
- Saber, 2018, Sex Differences in Maturation of Human Embryonic Stem Cell-Derived β Cells in Mice, Endocrinology, 159, 1827, 10.1210/en.2018-00048 · DOI
- Robert, 2018, Functional beta cell mass from device-encapsulated hESC-derived pancreatic endoderm achieving metabolic control, Stem Cell Reports, 10, 739, 10.1016/j.stemcr.2018.01.040 · DOI
- Chang, 2017, Nanoporous immunoprotective device for stem-cell-derived β-cell replacement therapy, ACS Nano, 11, 7747, 10.1021/acsnano.7b01239 · DOI
- Nathan, 1993, Long-term complications of diabetes mellitus, N. Engl. J. Med., 328, 1676, 10.1056/NEJM199306103282306 · DOI · Paper page
- Scharp, 1990, Insulin independence after islet transplantation into type I diabetic patient, Diabetes, 39, 515, 10.2337/diab.39.4.515 · DOI · Paper page
- Shapiro, 2000, Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen, N. Engl. J. Med., 343, 230, 10.1056/NEJM200007273430401 · DOI · Paper page
- Deuse, 2019, De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans, Nat. Biotechnol., 37, 1137, 10.1038/s41587-019-0227-7 · DOI
- de Rham, 2014, Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapy, J. Immunol. Res., 2014, 518135
- Park, 2020, Human induced pluripotent stem cell line banking for the production of rare blood type erythrocytes, J. Transl. Med., 18, 236, 10.1186/s12967-020-02403-y · doi:10.1186/s12967-020-02403-y
- Turinetto, 2017, Induced Pluripotent Stem Cells: Advances in the Quest for Genetic Stability during Reprogramming Process, Int. J. Mol. Sci., 18, E1952, 10.3390/ijms18091952 · DOI
- Ng, 2020, A comprehensive library of human transcription factors for cell fate engineering, Nat. Biotechnol.
- Cardenas-Diaz, 2020, A Dual Reporter EndoC-βH1 Human β-Cell Line for Efficient Quantification of Calcium Flux and Insulin Secretion, Endocrinology, 161, bqaa005, 10.1210/endocr/bqaa005 · DOI
- Kracht, 2018, Bioluminescent reporter assay for monitoring ER stress in human beta cells, Sci. Rep., 8, 17738, 10.1038/s41598-018-36142-4 · DOI
- Burns, 2015, High-throughput luminescent reporter of insulin secretion for discovering regulators of pancreatic Beta-cell function, Cell Metab., 21, 126, 10.1016/j.cmet.2014.12.010 · DOI
Cited by
Engineered cellular immunotherapies in cancer and beyond
Finck, A. V., Blanchard, T., Roselle, C. P., Golinelli, G., & June, C. H. (2022) · Nature Medicine · doi:10.1038/s41591-022-01765-8 · Cited by 269
Dadheech, N., Bermúdez de León, M., Czarnecka, Z., Cuesta-Gomez, N., Jasra, I. T., Pawlick, R., Marfil-Garza, B., Sapkota, S., Verhoeff, K., Razavy, H., et al. (2025) · npj Regenerative Medicine · doi:10.1038/s41536-025-00409-y · Cited by 23
Quality criteria for in vitro human pluripotent stem cell-derived models of tissue-based cells
Pistollato, F., Bal-Price, A., Coecke, S., Parvatam, S., Pamies, D., Czysz, K., Hao, J., Kee, K., Teo, A. K. K., Niu, S., et al. (2022) · Reproductive Toxicology · doi:10.1016/j.reprotox.2022.06.003 · Cited by 10
Metadata
- Authors
- Maxwell, K. G., & Millman, J. R.
- Venue
- Cell Reports Medicine
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 2
- Issue
- 4
- Pages
- 100238
- ISSN
- 2666-3791
- Cited by
- 113
- References
- 24
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- National Institutes of Health (R01DK114233, R01DK127497)
- Juvenile Diabetes Research Foundation United States of America (5-CDA-2017-391-A-N)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Applications of iPSC-derived beta cells from patients with diabetes. https://app.cochat.ai/papers/10.1016/j.xcrm.2021.100238
- The paper
- Maxwell, K. G., & Millman, J. R. (2021). Applications of iPSC-derived beta cells from patients with diabetes. Cell Reports Medicine. https://doi.org/10.1016/j.xcrm.2021.100238
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.